Theolytics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
33
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$2.59M
- Investors
-
8
Theolytics General Information
Description
Operator of the phenotypic screening platform intended to harness viruses to combat cancer. The company focuses on developing category-changing cancer therapies in the form of oncolytic viruses and its phenotypic screening approach helps the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimized for a chosen patient population, allowing doctors to deliver innovative care to patients.
Contact Information
Website
www.theolytics.comCorporate Office
- The Sherard Building
- Edmund Halley Road Oxford Science Park
- Oxford OX4 4DQ
- England, United Kingdom
Corporate Office
- The Sherard Building
- Edmund Halley Road Oxford Science Park
- Oxford OX4 4DQ
- England, United Kingdom
Theolytics Timeline
Theolytics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Grant | 02-Sep-2024 | $2.59M | Completed | Clinical Trials - Phase 1 | ||
7. Later Stage VC | 17-Apr-2024 | Completed | Clinical Trials - Phase 1 | |||
6. Grant | 01-May-2022 | Completed | Pre-Clinical Trials | |||
5. Early Stage VC (Series A2) | 08-Jul-2021 | Completed | Pre-Clinical Trials | |||
4. Grant | 01-Nov-2020 | Completed | Pre-Clinical Trials | |||
3. Accelerator/Incubator | 15-May-2020 | Completed | Pre-Clinical Trials | |||
2. Seed Round | 15-Dec-2017 | $3.34M | $3.34M | Completed | Startup | |
1. University Spin-Out | 01-Jan-2017 | Completed | Startup |
Theolytics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A2 | ||||||||
Series A1 | ||||||||
Series A | ||||||||
Series A | 4,192 | $0.001260 | $390.65 | $390.65 | 1x | $390.65 | 3.22% | |
Ordinary | 10,000 | $0.001260 | $315.04 | $315.04 | 1x | $315.04 | 7.68% |
Theolytics Comparisons
Industry
Financing
Details
Theolytics Competitors (3)
One of Theolytics’s 3 competitors is MiNA Therapeutics, a Venture Capital-Backed company based in London, United Kingdom.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
MiNA Therapeutics | Venture Capital-Backed | London, United Kingdom | ||||
Redx Pharma | Formerly VC-backed | Macclesfield, United Kingdom | ||||
Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom |
Theolytics Patents
Theolytics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-202401712-D0 | Adenoviruses | Pending | 08-Feb-2024 | ||
GB-202401719-D0 | Adenoviruses | Pending | 08-Feb-2024 | ||
GB-202401729-D0 | Adenoviruses | Pending | 08-Feb-2024 | ||
GB-202401715-D0 | Adenoviruses | Pending | 08-Feb-2024 | ||
GB-202319693-D0 | Adenoviruses | Pending | 20-Dec-2023 |
Theolytics Signals
Theolytics Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Sound Bioventures | Venture Capital | Minority | ||
Epidarex Capital | Venture Capital | Minority | ||
M Ventures | Corporate Venture Capital | Minority | ||
Taiho Ventures | Corporate Venture Capital | Minority | ||
Innovate UK | Accelerator/Incubator |
Theolytics FAQs
-
When was Theolytics founded?
Theolytics was founded in 2017.
-
Where is Theolytics headquartered?
Theolytics is headquartered in Oxford, United Kingdom.
-
What is the size of Theolytics?
Theolytics has 33 total employees.
-
What industry is Theolytics in?
Theolytics’s primary industry is Drug Discovery.
-
Is Theolytics a private or public company?
Theolytics is a Private company.
-
What is Theolytics’s current revenue?
The current revenue for Theolytics is
. -
How much funding has Theolytics raised over time?
Theolytics has raised $46.2M.
-
Who are Theolytics’s investors?
Sound Bioventures, Epidarex Capital, M Ventures, Taiho Ventures, and Innovate UK are 5 of 8 investors who have invested in Theolytics.
-
Who are Theolytics’s competitors?
MiNA Therapeutics, Redx Pharma, and Adaptimmune Therapeutics are competitors of Theolytics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »